SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
Jun 10, 2019
Document Date
Jun 6, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Akebia Therapeutics
Issuer
Akebia Therapeutics, Inc.
Filer
GILMAN STEVEN C
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet
Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142
+1 617.871.2098 phone
+1 617.871.2099 fax